A review of 329 CRC cases diagnosed in Israeli revealed a strong association between the UGT1A1-28/28 genotype and severe hematologic toxicity, increased hospitalization rate, and decreased survival rate in CRC patients undergoing Irinotecan treatment (55). This evidence concerns the gene UGT1A1 and colorectal carcinoma.